BMED ETF
iShares Health Innovation Active ETF
GILD is BMED's largest holding at 5.01% of the fund as of Aug 31, 2026. BMED is iShares Health Innovation Active ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | G | Gilead SciencesHealth Care · Pharmaceuticals | 5.01% | 5.0% | 4,627 | $677.1K | Health Care | Pharmaceuticals |
| 2 | M | Merck & Company IncHealth Care · Pharmaceuticals | 4.99% | 10.0% | 4,568 | $675.0K | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | A | AbbVie Inc. | 4.61% | 14.6% | 2,431 | $623.4K | ||
| 4 | J | Johnson & Johnson - | 4.27% | 18.9% | 2,172 | $577.4K | ||
| 5 | C | Charles River Laboratories International Inc | 4.22% | 23.1% | 1,981 | $571.0K | ||
| 6 | T | Thermo Fisherscientific Inc. | 4.12% | 27.2% | 902 | $556.6K | ||
| 7 | E | Edwards Lifesciences Corp | 3.95% | 31.2% | 5,880 | $533.6K | ||
| 8 | — | Moderna therapeutics | 3.86% | 35.0% | 3,722 | $522.3K | ||
| 9 | I | I Q V I A Holdings Inc. | 3.72% | 38.8% | 1,923 | $502.3K | ||
| 10 | D | Danaher Corp | 3.64% | 42.4% | 2,307 | $492.7K | ||
| 11 | — | Nvaesrtex Pharmaceuticals Inc | 3.56% | 46.0% | 884 | $481.4K | ||
| 12 | W | Waters Corp. | 3.53% | 49.5% | 1,150 | $476.8K | ||
| 13 | B | Biogen Inc. | 3.45% | 52.9% | 2,150 | $465.8K | ||
| 14 | M | Mettler-Toledo International Inc. | 3.16% | 56.1% | 304 | $427.2K | ||
| 15 | D | Dexcom Inc. | 2.61% | 58.7% | 3,881 | $353.4K | ||
| 16 | R | Roper Technologies Inc. | 2.61% | 61.3% | 807 | $352.4K | ||
| 17 | A | Amgen Inc. | 2.55% | 63.9% | 802 | $344.8K | ||
| 18 | I | Incyte Corp. | 2.40% | 66.3% | 2,631 | $324.2K | ||
| 19 | I | Illumina, Inc. | 2.15% | 68.4% | 1,363 | $291.2K | ||
| 20 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 2.11% | 70.5% | 277 | $285.8K | ||
| 21 | H | Halozyme Therapeutics Inc | 1.99% | 72.5% | 2,531 | $269.5K | ||
| 22 | — | Novartis Ag Sponsored Adr (1 Ads : 1 Ordinary) | 1.98% | 74.5% | 1,754 | $267.6K | ||
| 23 | — | - | 1.55% | 76.0% | 7,359 | $209.4K | ||
| 24 | B | Bristol-Myers Squibb Co. | 1.51% | 77.6% | 3,058 | $204.3K | ||
| 25 | C | Cytokinetics Inc | 1.51% | 79.1% | 2,888 | $204.8K | ||
| 26 | N | Neurocrine Biosciences Inc | 1.45% | 80.5% | 1,272 | $195.9K | ||
| 27 | A | Abbott Laboratories | 1.43% | 81.9% | 1,746 | $192.7K | ||
| 28 | G | Galderma Group N Ag | 1.38% | 83.3% | 896 | $186.2K | ||
| 29 | G | Guardant Health, Inc | 1.37% | 84.7% | 1,166 | $185.4K | ||
| 30 | — | Wuxi Biologics Cayman Inc | 1.34% | 86.0% | 29,000 | $180.7K | ||
| 31 | — | Roivant Sciences Ltd. Common Shares | 1.32% | 87.4% | 5,171 | $179.1K | ||
| 32 | — | Tempus Pe | 1.23% | 88.6% | 2,641 | $166.5K | ||
| 33 | B | Biomarin Pharmaceutical Inc. | 1.22% | 89.8% | 2,533 | $165.2K | ||
| 34 | R | Revolution Medicines Inc | 1.22% | 91.0% | 803 | $165.1K | ||
| 35 | A | Axsome Therapeutics Inc | 1.06% | 92.1% | 721 | $143.1K | ||
| 36 | P | Protagonist Therapeutics Inc | 0.95% | 93.0% | 866 | $128.0K | ||
| 37 | B | Bruker Corp. | 0.88% | 93.9% | 2,048 | $118.8K | ||
| 38 | — | Ucb Sa | 0.68% | 94.6% | 370 | $92.5K | ||
| 39 | — | USD Cash | 0.68% | 95.3% | 91,975 | $92.0K | ||
| 40 | — | Alkermes Plc. Ordinary Shares | 0.66% | 95.9% | 1,902 | $89.4K | ||
| 41 | A | Allogene Therapeutics Inc | 0.64% | 96.6% | 640 | $86.5K | ||
| 42 | R | Arcus Biosciences Inc | 0.62% | 97.2% | 2,851 | $83.5K | ||
| 43 | D | Dianthus Therapeutics Inc | 0.56% | 97.8% | 723 | $76.4K | ||
| 44 | M | Mbx Biosciences Inc | 0.50% | 98.3% | 1,103 | $67.9K | ||
| 45 | C | Cogent Biosciences Inc | 0.47% | 98.7% | 1,813 | $63.5K | ||
| 46 | Debt | Blackrock Cash Funds: Treasury, Sl Agency Shares | 0.37% | 99.1% | 50,000 | $50.0K | ||
| 47 | E | Erasca Inc. | 0.35% | 99.4% | 2,638 | $47.2K | ||
| 48 | S | Sagimet Biosciences Inc | 0.14% | 99.6% | 1,875 | $19.2K | ||
| 49 | A | Avalo Therapeuti | 0.12% | 99.7% | 867 | $16.8K | ||
| 50 | E | Eikon Therapeutics Inc | 0.11% | 99.8% | 1,392 | $14.6K | ||
| More holdings · Pro | ||||||||
BMED ETF All Holdings
BMED holdings total 61 positions. The top 10 holdings account for 42.4% of the fund, led by Gilead Sciences at 5.0%, Merck & Company Inc at 5.0%, Abbvie Inc. at 4.6%.
BMED portfolio concentration is moderate, with the top 10 representing 42.4% of total assets. The largest sector exposure is Health Care at 89.8%.
BMED sectors provide a detailed breakdown. BMED overlap shows how holdings compare to other funds in your portfolio.
BMED ETF Holdings
60 of 61 holdings
- 1
Gilead Sciences
GILDHealth Care5.01% - 2
Merck & Company Inc
MRKHealth Care4.99% - 3
Abbvie Inc.
ABBVHealth Care4.61% - 4
Johnson & Johnson - Common
JNJHealth Care4.27% - 5
Charles River Laboratories International Inc
CRLHealth Care4.22% - 6
Thermo Fisherscientific Inc.
TMOHealth Care4.12% - 7
Edwards Lifesciences Corp
EWHealth Care3.95% - 8
Moderna therapeutics
MRNAHealth Care3.86% - 9
I Q V I A Holdings Inc.
IQVHealth Care3.72% - 10
Danaher Corporation
DHRHealth Care3.64% - 11
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care3.56% - 12
Waters Corp.
WATHealth Care3.53% - 13
Biogen Inc. Com
BIIBHealth Care3.45% - 14
Mettler-Toledo International Inc.
MTDHealth Care3.16% - 15
Dexcom Inc.
DXCMHealth Care2.61% - 16
Roper Technologies Inc.
ROPIndustrials2.61% - 17
Amgen Inc.
AMGNHealth Care2.55% - 18
Incyte Corp.
INCYHealth Care2.40% - 19
Illumina, Inc.
ILMNHealth Care2.15% - 20
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care2.11% - 21
Halozyme Therapeutics Inc
HALOHealth Care1.99% - 22
Novartis Ag Sponsored Adr (1 Ads : 1 Ordinary)
NVS:SMHealth Care1.98% - 23
Pfizer
PFIZER:MBUnknown1.55% - 24
Bristol-Myers Squibb Co.
BMYHealth Care1.51% - 25
Cytokinetics Inc
CYTKHealth Care1.51% - 26
Neurocrine Biosciences Inc
NBIXHealth Care1.45% - 27
Abbott Laboratories
ABTHealth Care1.43% - 28
Galderma Group N Ag
GALD:SHUnknown1.38% - 29
Guardant Health, Inc
GHHealth Care1.37% - 30
Wuxi Biologics Cayman Inc
2269:HKUnknown1.34% - 31
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care1.32% - 32
Tempus Pe
TEMInformation Technology1.23% - 33
Biomarin Pharmaceutical Inc.
BMRNHealth Care1.22% - 34
Revolution Medicines Inc
RVMDHealth Care1.22% - 35
Axsome Therapeutics Inc
AXSMHealth Care1.06% - 36
Protagonist Therapeutics Inc
PTGXHealth Care0.95% - 37
Bruker Corp.
BRKRInformation Technology0.88% - 38
Ucb Sa
UCB:BRHealth Care0.68% - 39
USD Cash
Other0.68% - 40
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care0.66% - 41
Allogene Therapeutics Inc
APGEHealth Care0.64% - 42
Arcus Biosciences Inc
RCUSHealth Care0.62% - 43
Dianthus Therapeutics Inc
DNTHHealth Care0.56% - 44
Mbx Biosciences Inc
MBXHealth Care0.50% - 45
Cogent Biosciences Inc
COGTHealth Care0.47% - 46
Blackrock Cash Funds: Treasury, Sl Agency Shares
XTSLAFinancials0.37% - 47
Erasca Inc.
ERASHealth Care0.35% - 48
Sagimet Biosciences Inc
SGMTHealth Care0.14% - 49
Avalo Therapeuti
AVTXHealth Care0.12% - 50
Eikon Therapeutics Inc
EIKNUnknown0.11% - 51
Ultragenyx Pharmaceutical Inc
RAREHealth Care0.10% - 52
Summit Therapeutics
SMMTHealth Care0.07% - 53
Blueprint Medicines Corp
BPMCHealth Care0.00% - 54
Mirati Therapeutics Inc
MRTXUnknown0.00% - 55
HKD Cash
Other0.00% - 56
Korro Bio Inc Cvr
Other0.00% - 57
Vigil Neuroscience Inc Cvr
Other0.00% - 58
GBP Cash
Other0.00% - 59
Abiomed Cvrs
Other0.00% - 60
KRW Cash
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Gilead Sciences | GILD | 5.010% | ||
| 2 | Merck & Company Inc | MRK | 4.990% | ||
| 3 | Abbvie Inc. | ABBV | 4.610% | ||
| 4 | Johnson & Johnson - Common | JNJ | 4.270% | ||
| 5 | Charles River Laboratories International Inc | CRL | 4.220% | ||
| 6 | Thermo Fisherscientific Inc. | TMO | 4.120% | ||
| 7 | Edwards Lifesciences Corp | EW | 3.950% | ||
| 8 | Moderna therapeutics | MRNA | 3.860% | ||
| 9 | I Q V I A Holdings Inc. | IQV | 3.720% | ||
| 10 | Danaher Corporation | DHR | 3.640% | ||
| 11 | Nvaesrtex Pharmaceuticals Inc | VRTX | 3.560% | ||
| 12 | Waters Corp. | WAT | 3.530% | ||
| 13 | Biogen Inc. Com | BIIB | 3.450% | ||
| 14 | Mettler-Toledo International Inc. | MTD | 3.160% | ||
| 15 | Dexcom Inc. | DXCM | 2.610% | ||
| 16 | Roper Technologies Inc. | ROP | 2.610% | ||
| 17 | Amgen Inc. | AMGN | 2.550% | ||
| 18 | Incyte Corp. | INCY | 2.400% | ||
| 19 | Illumina, Inc. | ILMN | 2.150% | ||
| 20 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 2.110% | ||
| 21 | Halozyme Therapeutics Inc | HALO | 1.990% | ||
| 22 | Novartis Ag Sponsored Adr (1 Ads : 1 Ordinary) | NVS:SM | 1.980% | ||
| 23 | Pfizer | PFIZER:MB | 1.550% | ||
| 24 | Bristol-Myers Squibb Co. | BMY | 1.510% | ||
| 25 | Cytokinetics Inc | CYTK | 1.510% | ||
| 26 | Neurocrine Biosciences Inc | NBIX | 1.450% | ||
| 27 | Abbott Laboratories | ABT | 1.430% | ||
| 28 | Galderma Group N Ag | GALD:SH | 1.380% | ||
| 29 | Guardant Health, Inc | GH | 1.370% | ||
| 30 | Wuxi Biologics Cayman Inc | 2269:HK | 1.340% | ||
| 31 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 1.320% | ||
| 32 | Tempus Pe | TEM | 1.230% | ||
| 33 | Biomarin Pharmaceutical Inc. | BMRN | 1.220% | ||
| 34 | Revolution Medicines Inc | RVMD | 1.220% | ||
| 35 | Axsome Therapeutics Inc | AXSM | 1.060% | ||
| 36 | Protagonist Therapeutics Inc | PTGX | 0.950% | ||
| 37 | Bruker Corp. | BRKR | 0.880% | ||
| 38 | Ucb Sa | UCB:BR | 0.680% | ||
| 39 | USD Cash | - | 0.680% | ||
| 40 | Alkermes Plc. Ordinary Shares | ALKS:IE | 0.660% | ||
| 41 | Allogene Therapeutics Inc | APGE | 0.640% | ||
| 42 | Arcus Biosciences Inc | RCUS | 0.620% | ||
| 43 | Dianthus Therapeutics Inc | DNTH | 0.560% | ||
| 44 | Mbx Biosciences Inc | MBX | 0.500% | ||
| 45 | Cogent Biosciences Inc | COGT | 0.470% | ||
| 46 | Blackrock Cash Funds: Treasury, Sl Agency Shares | XTSLA | 0.370% | ||
| 47 | Erasca Inc. | ERAS | 0.350% | ||
| 48 | Sagimet Biosciences Inc | SGMT | 0.140% | ||
| 49 | Avalo Therapeuti | AVTX | 0.120% | ||
| 50 | Eikon Therapeutics Inc | EIKN | 0.110% | ||
| 51 | Ultragenyx Pharmaceutical Inc | RARE | 0.100% | ||
| 52 | Summit Therapeutics | SMMT | 0.070% | ||
| 53 | Blueprint Medicines Corp | BPMC | 0.000% | ||
| 54 | Mirati Therapeutics Inc | MRTX | 0.000% | ||
| 55 | HKD Cash | - | 0.000% | ||
| 56 | Korro Bio Inc Cvr | - | 0.000% | ||
| 57 | Vigil Neuroscience Inc Cvr | - | 0.000% | ||
| 58 | GBP Cash | - | 0.000% | ||
| 59 | Abiomed Cvrs | - | 0.000% | ||
| 60 | KRW Cash | - | 0.000% |





































